Ernexa Therapeutics
CompanyUnited States
Ernexa Therapeutics develops one asset, preclinical (ERNA-101 in cancer). Mostly other; based in the United States.
- 1
- Asset
- Furthest stage
- Preclinical
- 0
- Trials
- 0
- Signals
Pipeline
1Oncology therapeutic designed to clear tumors in combination with anti-PD-1.
Preclinical, Other, cancer, solid tumor
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Similar companies6